MODERATE PSORIASIS
Clinical trials for MODERATE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New psoriasis drug study aims to clear skin and restore quality of life
Disease control OngoingThis study observes how well the approved medication risankizumab works for people recently diagnosed with moderate plaque psoriasis in real-world Greek clinics. About 250 participants who haven't tried advanced treatments will be followed for two years while taking risankizumab …
Matched conditions: MODERATE PSORIASIS
Sponsor: AbbVie • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Major psoriasis drug trial tests if skin relief lasts
Disease control OngoingThis study is checking if a medication called ESK-001 is safe and keeps working for people with moderate-to-severe plaque psoriasis over a long period. It involves 1,680 adults who have already taken ESK-001 in a previous study. The research will see if the drug's benefits last a…
Matched conditions: MODERATE PSORIASIS
Phase: PHASE3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC